BioSpace News Archive

According to the latest news from Science and Technology Daily, two COVID-19 inactivated vaccines were just approved for a phase I & II combined clinical trial by the National Medical Products Administration of China, making them the first batch in this category.

The new Kerecis telemedicine service, TeleKer™, enables healthcare providers to get timely, personalized advice on how to treat wounds with Kerecis products.

Quattroflow, part of PSG® and Dover (NYSE: DOV), today announced it has extended its line of multiple- and single-use pumps with the introduction of the new Quattroflow™ QF2500 Quaternary Diaphragm Pump (the “QF2500 pump”).

Universal Health Services, Inc. announced that it will report results for its first quarter ended March 31, 2020 after the market closes on Monday, April 27, 2020.

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced that its 2020 Annual Meeting of Stockholders (the “Annual Meeting”) will be a virtual meeting instead of an in-person meeting. This change is in response to the ongoing COVID-19 pandemic and is intended to protect the health and safety of Amneal’s stockholders and employees. The Annual Meeting will be held Tuesday, May 5, 2020 a

According to the latest market report published by Persistence Market Research, titled ‘Global Ambulance Stretchers Market: Global Industry Analysis 2013 – 2017 and Forecast 2018 – 2026’, the Global Ambulance Stretchers market is expected to expand at a CAGR of 2.2% over the forecast period 2018–2026.

The use of corneal implants is gathering momentum around the world, owing to their proven efficacy for the correction of presbyopia by improving near and intermediate vision without any detriment to distant vision.

As some communities face the peak of the COVID-19 outbreak in their area, others are preparing for a surge of COVID-19 related cases.

Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon technologies to address unmet medical needs, today announced that the United States (U.S.) Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to TransCon hGH ( lonapegsomatropin ), as a treatment for growth hormone deficiency (GHD). TransCon hGH is an investigational long-acting prodrug of somatropin (human gro

T2 Biosystems, Inc. a leader in the rapid detection of sepsis-causing pathogens, announced that it issued inducement awards to four new employees.